Wall Street Financial Group’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-67
Closed -$13.5K 296
2026
Q1
$13.5K Buy
+67
New +$13.9K 0.01% 447

Other funds holding FBT

Wall Street Financial Group's FBT Position: Q2 2026 in Review

Wall Street Financial Group sold out of First Trust NYSE Arca Biotechnology Index Fund (FBT) in Q2 2026, closing a stake of 67 shares — an estimated $13.5K sold.

Wall Street Financial Group first reported a position in FBT in Q1 2026 and held it in 1 quarter. The position peaked at $13.5K in Q1 2026. 51 funds tracked by Wall St. Rank hold FBT as of Q2 2026.

  • Wall Street Financial Group reported no remaining First Trust NYSE Arca Biotechnology Index Fund position as of Q2 2026 after selling out during the quarter.
  • Wall Street Financial Group sold 67 First Trust NYSE Arca Biotechnology Index Fund shares in Q2 2026, an estimated $13.5K.
  • Wall Street Financial Group first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q1 2026 and held it in 1 quarter.
  • Wall Street Financial Group's First Trust NYSE Arca Biotechnology Index Fund position peaked at $13.5K in Q1 2026.
  • 51 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q2 2026.

Based on Wall Street Financial Group's 13F filing for Q2 2026, filed 14 Jul 2026.